Skip to Main Content

Paper Details

Modeling Patient-Specific Muscular Dystrophy Phenotypes and Therapeutic Responses in Reprogrammed Myotubes Engineered on Micromolded Gelatin Hydrogels.
Front Cell Dev Biol
3
2022
DMD, Duchenne muscular dystrophy, LGMD2A, LGMD2A/R1, Limb Girdle 2A/R1, Muscular Dystrophy, MyoD, MyoD-directly reprogrammed fibroblasts, Patient, Reprogrammed Myotubes, dermal fibroblasts, dystrophic muscle, dystrophin, dystrophin protein, exon 44 or 45, genetic muscle defects, mRNA, multinucleated, muscle lineage, muscular dystrophies, myotube, myotubes, patient, patients, reprogrammed patient fibroblasts
Author NameAffiliation
Stanley F NelsonCenter for Duchenne Muscular Dystrophy, University of California los angeles
Stanley F NelsonDavid Geffen School of Medicine, University of California los angeles
Stanley F NelsonDavid Geffen School of Medicine, University of California los angeles
Stanley F NelsonCenter for Duchenne Muscular Dystrophy, University of California los angeles
Stanley F NelsonDavid Geffen School of Medicine, University of California los angeles
Stanley F NelsonDavid Geffen School of Medicine, University of California los angeles
  • 1 - 6

Datasets

Release 1.2